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INTRODUCTION
Based on five randomized clinical trials, endovascular 
mechanical thrombectomy (EVT) is recommended as a 
standard treatment for anterior circulation large vessel 
occlusion (AC-LVO) (1, 2). In addition, the diffusion-
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Objective: Endovascular thrombectomy (EVT) fails in approximately 20% of anterior circulation large vessel occlusion (AC-
LVO). Nonetheless, the factors that affect clinical outcomes of non-recanalized AC-LVO despite EVT are less studied. The 
purpose of this study was to identify the factors affecting clinical outcomes in non-recanalized AC-LVO patients despite EVT. 
Materials and Methods: This was a retrospective analysis of clinical and imaging data from 136 consecutive patients who 
demonstrated recanalization failure (modified thrombolysis in cerebral ischemia [mTICI], 0–2a) despite EVT for AC-LVO. Data 
were collected in prospectively maintained registries at 16 stroke centers. Collateral status was categorized into good or poor 
based on the CT angiogram, and the mTICI was categorized as 0–1 or 2a on the final angiogram. Patients with good (modified 
Rankin Scale [mRS], 0–2) and poor outcomes (mRS, 3–6) were compared in multivariate analysis to evaluate the factors 
associated with a good outcome. 
Results: Thirty-five patients (25.7%) had good outcomes. The good outcome group was younger (odds ratio [OR], 0.962; 
95% confidence interval [CI], 0.932–0.992; p = 0.015), had a lower incidence of hypertension (OR, 0.380; 95% CI, 0.173–
0.839; p = 0.017) and distal internal carotid artery involvement (OR, 0.149; 95% CI, 0.043–0.520; p = 0.003), lower initial 
National Institute of Health Stroke Scale (NIHSS) (OR, 0.789; 95% CI, 0.713–0.873; p < 0.001) and good collateral status 
(OR, 13.818; 95% CI, 3.971–48.090; p < 0.001). In multivariate analysis, the initial NIHSS (OR, 0.760; 95% CI, 0.638–
0.905; p = 0.002), good collateral status (OR, 14.130; 95% CI, 2.264–88.212; p = 0.005) and mTICI 2a recanalization (OR, 
5.636; 95% CI, 1.216–26.119; p = 0.027) remained as independent factors with good outcome in non-recanalized patients.
Conclusion: Baseline NIHSS score, good collateral status, and mTICI 2a recanalization remained independently associated 
with clinical outcome in non-recanalized patients. mTICI 2a recanalization would benefit patients with good collaterals in 
non-recanalized AC-LVO patients despite EVT.
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weighted imaging or CT perfusion assessment with clinical 
mismatch in the triage of wake up and late presenting 
stroke undergoing neurointervention with Trevo (DAWN) 
and Endovascular Therapy Following Imaging Evaluation 
for Ischemic Stroke-3 (DEFUSE-3) trials demonstrated the 
benefit of EVT in late-presenting AC-LVO through strict 
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Review Board of every participating hospital approved this 
study (IRB No: 4-2017-0511) and waived the requirement 
for informed consent for study inclusion based on the 
retrospective study design.
Data Collection and Assessment
Data collection and assessment methods were described 
in a previous report (10). Briefly, the Alberta Stroke 
Program Early CT Score (ASPECTS) was independently 
evaluated from 5-mm-thick non-contrast CT images by two 
neuroradiologists. The collateral status on single-phase CTA 
with 20-mm-thick maximum intensity projection images 
was assessed with a commercialized DICOM viewer (OsiriX, 
Pixmeo, Geneva, Switzerland). For multiphase CTA, only the 
first-phase CTA was used to evaluate the collateral status, 
which was categorized into either good or poor. According 
to the pial arterial filling score within the symptomatic 
ischemic territory using single phase CTA (11), good 
collateral status was defined as score 4 (slightly reduced 
prominence and extent of the pial vessel) and 5 (increased 
or normal prominence and extent of the pial vessels) within 
the ischemic territory in the symptomatic hemisphere. 
Patients with poorly identified vessel markings compared 
to the contralateral, unaffected hemisphere in CTA were 
excluded to reduce misclassification. In addition, if the 
occlusion site was located at the origin of the P-com of the 
distal ICA or the A1 orifice of the anterior cerebral artery 
in digital subtraction angiography, we classified it into a 
distal ICA involvement, as involvement of these sites could 
interfere with the collateral supply of brain. Beyond the 
distal ICA involvement was defined as the occlusion site 
located at the M1 or M2 segment of the MCA above the A1 
orifice. In the case of tandem occlusion, the involvement 
of the distal ICA or beyond the distal ICA was determined 
based on where the distal occluded segment was located. 
Two investigators blinded to the ASPECTS, the collateral 
status, and the clinical outcome independently assessed 
recanalization success. Recanalization failure was defined 
as mTICI grade 0–2a on the final control angiogram and 
further categorized as 0–1 and 2a. Kappa values for inter-
rater agreement of the collateral grade (good or poor), 
mTICI (0–2a vs. 2b–3), and mTICI (0–1 vs. 2a) were 0.875, 
0.813, and 0.905, respectively. Disagreement between raters 
was resolved by consensus. If the recanalization after EVT 
was not assessed due to poor image quality, the case was 
classified as undetermined and excluded from the analysis. 
patient selection criteria (3, 4).
The selection criteria in many clinical trials for EVT 
were developed to identify factors related to patient 
outcomes after EVT. Lower initial National Institutes of 
Health Stroke Scale (NIHSS), shorter procedure time, 
smaller early ischemic change on non-contrast computed 
tomography (CT), lower serum glucose, good collateral 
status, and recanalization success were predictive factors 
for good outcome after EVT (5-9). Among them, successful 
recanalization (defined as modified thrombolysis in cerebral 
infarction scale [mTICI] grade 2b or 3) was the most 
important factor for patient outcomes after EVT (9).
In an era of modern EVT, approximately 20% of patients 
do not achieve successful recanalization (3, 4). However, to 
our knowledge, the prognosis and factors that affect clinical 
outcomes in patients without successful recanalization 
despite modern EVT are not well known. In this study, 
we intended to evaluate the prognostic factors in non-
recanalized AC-LVO patients despite EVT. 
MATERIALS AND METHODS
Patient Enrollment
This was a retrospective analysis of data from 
prospectively maintained registries collected between 
September 2010 and December 2015. The current study 
was initiated by the Korean Health Technology R&D Project 
and involved 16 stroke centers across Korea. The registries 
enrolled consecutive patients who underwent EVT with a 
stent retriever (Solitaire AB/FR, ev3, Irvine, CA, USA; Trevo 
Proview, Stryker, CA, USA), contact aspiration (Penumbra, 
Alameda, CA, USA), or a combined approach for acute 
ischemic stroke caused by AC-LVO. These patients had a 
modified Rankin Scale (mRS) score available at 3 months. 
AC-LVO was defined as occlusion of the internal carotid 
artery (ICA), M1 portion of the middle cerebral artery (MCA), 
or proximal M2 portion of the MCA. 
Enrollment criteria for this study were as follows: 1) age ≥ 
18 years; 2) initial NIHSS ≥ 4; 3) onset to puncture time ≤ 
600 minutes; 4) mRS of 0 or 1 before the qualifying stroke; 
5) collateral status assessable on computed tomography 
angiography (CTA); and 6) recanalization success or failure 
assessable on catheter angiogram during the procedure. 
Intracranial AC-LVO accompanying cervical ICA dissection 
or tandem occlusion was also included. However, AC-
LVO caused by intracranial artery dissection and bilateral 





Clinical outcomes were evaluated by mRS at 3 months 
in all patients who fulfilled the enrollment criteria. Good 
outcome was defined as mRS 0–2 at 3 months after stroke. 
Patients were categorized into good or poor outcome 
groups. We analyzed factors associated with good outcomes 
in non-recanalized patients despite EVT.
Statistical Analysis
The data are presented as a mean ± standard deviation, 
median (interquartile range [IQR]), or as a number 
(percent), as appropriate. Differences between good and 
poor outcomes were compared with a chi-square test, 
Fisher’s exact test, Student’s t test, and a Mann-Whitney 
U test, as appropriate. To determine the independent 
prognostic factors for good outcomes in non-recanalized 
patients, binary logistic regression analysis was performed 
and summarized as an odd ratio (OR) and 95% confidential 
interval (CI). For multivariate analysis, variables with p < 
0.2 in the univariate analysis were included in the binary 
logistic regression analysis. All tests were two-sided, and 
finally, p < 0.05 was considered statistically significant. 
In addition, the final model was fitted using the Hosmer-
Lemeshow Goodness of Fit Test and p > 0.05 was considered 
as the model fit to the binary logistic regression analysis 
(12). We used the variance inflation factor to assess the 
multicollinearity among the variables included in the 
multivariate analysis. All statistical analyses were performed 
with IBM SPSS Statistics version 23 (IBM Corp., Armonk, 
NY, USA) and R software version 3.6.1 (R Foundation for 
Statistical Computing, Vienna, Austria). 
RESULTS
Altogether, 805 patients had undergone EVT for acute 
ischemic stroke with a stent retriever, penumbra, or both 
between September 2010 and December 2015. Among 
them, 765 patients (95.0%) had mRS available at 3 months, 
of whom 690 (90.2%) fulfilled the enrolment criteria. Of 
these 690 patients, 136 (19.7%) had recanalization failure 
despite EVT and were enrolled in this study (Fig. 1).
Thirty-five (25.7%) of the non-recanalized patients had 
good outcome. The good outcome group was younger, 
had a lower incidence of hypertension, lower distal ICA 
involvement, and lower initial NIHSS and good collateral 
status (Table 1). 
In univariate analysis, the initial NIHSS, good 
collateral status, and beyond distal ICA involvement were 
associated with good outcome. In addition, the distal ICA 
involvement was negatively associated with good outcome 
(Table 1). After adjusting for potentially associated 
factors in univariate analysis (p < 0.20), including age, 
hypertension, initial NIHSS, mTICI 2a recanalization, 
distal ICA involvement, beyond distal ICA involvement 
and good collateral status, the initial NIHSS (OR, 0.760; 
95% CI, 0.638–0.905, p = 0.002), good collateral status 
(OR, 14.130; 95% CI, 2.264–88.212, p = 0.005) and mTICI 
2a recanalization (OR, 5.636; 95% CI, 1.216–26.119, p = 
0.027) remained independent factors with good outcome 
in non-recanalized patients (Table 1). The model was fairly 
calibrated (p = 0.599 by the Hosmer-Lemeshow test) with 
reasonable discrimination (C statistics = 0.915). 
DISCUSSION
The patients with mTICI 2a recanalization and good 
Fig. 1. Flow chart of patients’ inclusion. CTA = computed 
tomography angiography, EVT = endovascular thrombectomy, ICA = 
internal carotid artery, mRS = modified Rankin Scale, mTICI = modified 
thrombolysis in cerebral ischemia, NIHSS = National Institutes of 
Health Stroke Scale
765 patients
- Acute stroke due to occlusion of intracranial ICA, M1 or proximal M2
- EVT was done using stent retriever, penumbra, or both
- mRS at 3 months was available
690 patients (90.2%)
- Age ≥ 4
- Initial NIHSS ≥ 4
- Onset to puncture time ≤ 600 minutes
- mRS before qualifying stroke was 0 or 1
- Collateral grading on CTA was assessable
- Recanalization success was assessable
mTICI 0–2a after EVT (n = 136, 19.7%)
75 patients (7.8%) excluded
- Initial NIHSS < 4
-  Onset to puncture time  
> 600 minutes




(n = 35, 25.7%)
Poor outcome group
mRS 3–6
(n = 101, 74.3%)
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(20). Moreover, the degree of ischemic vascular injury after 
vessel occlusion can be minimized by the collateral supply. 
Thus, the response to intravenous tissue plasminogen 
activator and EVT could be improved in patients with good 
collaterals (12). In addition, the time to reperfusion to 
improve the likelihood of good outcome can be adjusted 
for the collateral status (10), which was an important 
background factor in the late window trials, such as DAWN 
and DEFUSE-3 (3, 4). 
In our study, we also confirmed that good collateral 
status was significantly associated with good outcomes 
even in the case of a failed EVT. In addition, mTICI 2a 
recanalization provided benefit for the outcome of patients 
with failed EVT. According to previous reports, the presence 
of proximal artery occlusion without absence of early 
recanalization led to neurological deterioration through 
hemodynamic compromise (21). This result indicates that 
good collateral status does not completely protect brain 
tissue; rather delays ischemic injury in various ways. 
Alternatively, timely recanalization in addition to good 
collateral status is essential for achieving a good outcome. 
Similarly, mTICI 2a recanalization may have a more positive 
effect on clinical outcome in patients with good collaterals; 
collateral had a relatively higher probability of good 
outcome in the recanalization failure group. This study 
is, to our knowledge, the first to identify prognostic 
factors associated with clinical outcomes in patients with 
recanalization failure, despite modern EVT.
Recanalization success is one of the most important 
factors affecting clinical outcome in patients who receive 
EVT (9). Conventionally, recanalization is defined as mTICI 
2b (contrast agent filling more than 50% of the affected 
artery) or 3 (complete filling). The mTICI 2a recanalization 
is defined as the contrast agent filling less than 50% of the 
affected vascular territory. The mTICI 0 and 1 are defined 
as no or minimal recanalization (perfusion past the initial 
obstruction but limited distal branch filling with little or no 
distal perfusion), respectively. For example, if a patient had 
an occlusion of the right MCA M1 segment, recanalization of 
either the superior or the inferior M2 division alone might 
be graded as mTICI 2a. Intuitively, mTICI 2a reperfusion 
can benefit patients more than mTICI 0 or 1. 
The collateral status has been suggested as a strong 
predictor for both recanalization success and functional 
outcome (13-19). Retrograde collateral filling may help 
thrombolytic agents to access the distal aspects of a clot 






Univariate Analysis Multivariate Analysis
OR (95% CI) P OR (95% CI) P
Age, years 63.5 ± 12.2 69.4 ± 11.6 0.012 0.962 (0.932–0.992) 0.015 0.968 (0.909–1.030) 0.304
Male 20 (57.1) 45 (44.6) 0.276 1.659 (0.764–3.605) 0.201
Hypertension 17 (48.6) 72 (71.3) 0.026 0.380 (0.173–0.839 0.017 0.778 (0.162–3.741) 0.778
Diabetes 8 (22.9) 30 (29.7) 0.576 0.701 (0.285–1.720) 0.438
Hyperlipidemia 3 (8.6) 11 (10.9) 0.947 0.767 (0.201–2.926) 0.698
Smoking 11 (31.4) 27 (26.7) 0.753 1.256 (0.543–2.906) 0.594
CAOD 7 (20.0) 16 (15.8) 0.761 1.328 (0.496–3.558) 0.573
Atrial fibrillation 15 (42.9) 51 (50.5) 0.560 0.735 (0.339–1.596) 0.437
Previous ischemic stroke 3 (8.6) 18 (17.8) 0.301 0.432 (0.119–1.568) 0.202
Initial NIHSS 12 (5–19) 17 (9–25) < 0.001 0.789 (0.713–0.873) < 0.001 0.760 (0.638–0.905) 0.002
ASPECT 8 (6–10) 8 (6–10) 0.093 1.399 (0.942–2.079) 0.096 1.023 (0.556–1.883) 0.942
mTICI 2a 17 (48.6) 36 (35.6) 0.250 1.705 (0.783–3.712) 0.179 5.636 (1.216–26.119) 0.027
Good collateral 32 (91.6) 44 (43.6) < 0.001 13.818 (3.971–48.090) < 0.001 14.130 (2.264–88.212) 0.005
IV-tPA 16 (45.7) 47 (46.5) 1.000 0.968 (0.447–2.093) 0.999
Distal ICA involvement 3 (8.6) 39 (38.6) 0.002 0.149 (0.043–0.520) 0.003 0.205 (0.033–14.271) 0.464
Beyond distal ICA inolvement 32 (91.4) 73 (72.3) 0.036 4.091 (1.159–14.439) 0.029 0.229 (0.003–16.070) 0.497
M1 segment of MCA 21 (65.6) 64 (87.7)
M2 segment of MCA 11 (34.4) 9 (12.3)
Initial glucose, mg/dL 129.6 ± 54.2 151.6 ± 102.5 0.124 0.994 (0.984–1.004) 0.227
Data are shown as number (%), mean ± standard deviation, or median (interquartile range). ASPECT = Alberta Stroke Program Early CT 
score, CAOD = coronary artery occlusive disease, CI = confidence interval, ICA = internal carotid artery, IV = intravenous, MCA = middle 
cerebral artery, mRS = modified Rankin Scale, mTICI = modified thrombolysis in cerebral ischemia, NIHSS = National Institute of Health 




however, non-recanalization in all poor collateral patients 
resulted in poor outcome regardless of the mTICI grade (0–1 
vs. 2a). 
Previous studies identified younger age, lower NIHSS, 
good collateral, lower serum glucose, lower ASPECTS, 
and successful recanalization as independent predictors 
for good outcome (5-9). In our study, age and baseline 
ASPECTS were not associated with good outcomes in the 
non-recanalization group. Good outcome is less common 
in patients > 80 years (22). In this study, most patients 
were younger than 80 years, and age did not differ 
significantly between the groups. In addition, baseline 
ASPECTS was similar in the two groups in this study. Thus, 
ASPECTS did not affect patient outcome. Lower NIHSS was 
an independent predictive factor for good outcome after 
successful recanalization (23). As the collateral status was 
categorized as good or poor in this study, it might not 
reflect a detailed status. Initial neurological severity may 
reflect a more precise collateral status even among the good 
collateral group and, thus, remain independently associated 
with the clinical outcome. 
Finally, the use of tissue plasminogen activator (tPA) 
was not associated with good outcome in this study. 
Currently, the question whether EVT without prior tPA is 
better or worse than EVT with tPA has been of concern. 
(24, 25) The benefits of tPA before EVT is that tPA can 
lead to spontaneous successful recanalization before EVT, 
especially in the case of near-occlusion or short thrombi 
and significantly lowers the number of passes required to 
achieve successful recanalization (26). Alternatively, tPA 
can help achieve successful recanalization, which may lead 
to a good outcome. In our study, we only included the non-
recanalized AC-LVO patients despite EVT. Thus, the effect of 
tPA may be limited. 
This study had some strengths and limitations. Many 
attributable reasons regarding failure to achieve successful 
recanalization, defined as mTICI 2b–3, have been suggested 
(27). We did not collect the information regarding reasons 
of failure of EVT and the point when EVT attempts were 
discontinued, as the EVT strategy of each participating 
hospital was different. Nevertheless, the primary focus 
of this study was to determine the predictors for a good 
outcome despite a failed EVT. The collateral status was 
assessed with single-phase CTA, as it is the most widely 
used modality at the participating centers (93.5% of 
enrolled patients). Due to delayed circulation time 
after beginning the CTA scan, contrast agent filling of 
cerebral arteries through collaterals on single-phase CT is 
insufficient. Thus, using single-phase CTA can result in good 
collaterals misclassified as poor collaterals. However, we 
only included patients with clearly visible vessel markings 
in the contralateral normal hemisphere. In addition, we only 
included the first phase image for patients who underwent 
multiphase CTA to increase inter-rater agreement. Finally, 
mTICI 2a recanalization and good collateral illustrated a 
wide range of confidence interval due to our relatively small 
sample size. Thus, future studies with a large sample size 
are required. Therefore, interrater agreement was excellent 
for the discrimination of poor and good collateral status and 
for of mTICI 0–1 and mTICI 2a. Despite the retrospective 
nature of our study, our study population represents at least 
10% of all patients who received EVT in Korea during the 
study period, based on nationwide data from the Health 
Insurance Review and Assessment Service. Therefore, the 
results of this study reflect real-world practice in Korea. 
In conclusion, lower initial NIHSS, good collateral, and 
mTICI 2a recanalization were independent predictors of 
good outcome in patients with recanalization failure despite 
EVT. This result suggests that mTICI 2a recanalization would 
benefit patients with good collateral, even if recanalization 
were not successful despite EVT.
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